BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1377462)

  • 21. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum tumour markers in testicular and extragonadal germ cell malignancies.
    Klepp O
    Scand J Clin Lab Invest Suppl; 1991; 206():28-41. PubMed ID: 1947758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
    Weissbach L; Bussar-Maatz R; Mann K
    Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
    Mazumdar M; Bacik J; Tickoo SK; Dobrzynski D; Donadio A; Bajorin D; Motzer R; Reuter V; Bosl GJ
    J Clin Oncol; 2003 Jul; 21(14):2679-88. PubMed ID: 12860944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor markers in testis cancer.
    Klein EA
    Urol Clin North Am; 1993 Feb; 20(1):67-73. PubMed ID: 7679533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The diagnostic and prognostic value of tumor markers in nonseminomatous stage-III to -IV testicular tumors].
    Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
    Urol Nefrol (Mosk); 1989; (3):42-6. PubMed ID: 2475955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of plasma tumor markers in germinal tumors of the testis].
    Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
    Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the management of testicular cancer.
    Ellis M; Sikora K
    Drugs Exp Clin Res; 1986; 12(1-3):219-31. PubMed ID: 2426072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sterility and tumors of the testis. Study of late exocrine and endocrine functions in stage I or IIA tumors].
    Bouchot O; Plougastel ML; Karam G; Bochereau G; Auvigne J
    J Urol (Paris); 1989; 95(6):367-71. PubMed ID: 2478640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphologic criteria for the evaluation of beta-HCG positive seminoma].
    Scherenberg M; Schubert GE
    Urologe A; 1993 Jan; 32(1):38-42. PubMed ID: 7680507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
    Weisberger EC; McBride LC
    Laryngoscope; 1999 Aug; 109(8):1241-4. PubMed ID: 10443827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes].
    Nonomura N; Imazu T; Harada Y; Nozawa M; Ono Y; Fukui T; Nishimura K; Okuyama A
    Hinyokika Kiyo; 1999 Aug; 45(8):593-7. PubMed ID: 10500969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical study of testicular germ cell tumors.
    Tomomasa H; Shimizu H; Sato S; Adachi Y; Ashizawa Y; Kamiyama Y; Okano Y; Sato M; Yoshii T; Iizumi T; Umeda T; Yazaki T
    Hinyokika Kiyo; 2001 Jun; 47(6):389-95. PubMed ID: 11496394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Testicular tumor staging: the ranking of CT and ultrasonic diagnosis].
    Hruby W; Stellamor K; Höltl W; Pont J
    Rontgenblatter; 1984 Apr; 37(4):123-6. PubMed ID: 6729361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evidence of biochemical markers in a complex diagnostico-therapeutic program in germ cell tumors of the testes].
    Abrahámová J; Motlík K; Malbohan I; Wernischová V
    Cas Lek Cesk; 1983 Jul; 122(26):824-9. PubMed ID: 6193884
    [No Abstract]   [Full Text] [Related]  

  • 37. [Differentiated teratoma as late recurrence of metastatic non-seminomatous testicular germ cell tumor. Case report and clinical problems].
    Kuczyk MA; Bokemeyer C; Fichna B; Truss M; Schmoll HJ; Jonas U
    Urologe A; 1995 Nov; 34(6):480-4. PubMed ID: 8848861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic indications for germinal testicular tumors].
    Bourlaud G; Houlgatte A; Merrer J; Pabot du Chatelard P
    Ann Urol (Paris); 1992; 26(2):119-24. PubMed ID: 1616300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor markers in testicular cancer].
    Mann K
    Urologe A; 1990 Mar; 29(2):77-86. PubMed ID: 2158684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance after orchidectomy for clinical stage I testicular non-seminoma.
    Peckham MJ
    Prog Clin Biol Res; 1984; 153():155-65. PubMed ID: 6206505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.